The Transgenic/Gene Knockout Facility was developed to provide the physical resources and technical expertise for generation of transgenic and gene knockout mice for the research needs of the EHS Center members. The facility is directed by Dr. Ye-Shih Ho. As proposed, the facility could provide complete handling of a project, from isolation of a cDNA to construction of the expression gene to screening of the F0 pups to identifying animals carrying the transgene. Dr. Ho proposes to provide nine services to investigators from the Center; these include: 1) design and construction of expression vectors for generation of transgenic animals; 2) preparation of DNA for microinjection; 3) maintenance of stock mice and various lines of transgenic and knockout mice; 4) microinjection of DNA into fertilized eggs and surgical implantation of the microinjected embryos into pseudopregnant recipients; 5) screening and identifying of transgenic mice; 6) assistance on construction of gene targeting vector and culturing and screening of ES cells; 7) microinjection of mouse blastocysts with ES cells for generation of gene knockout mice; 8) training in the production of transgenic mice; and 9) consultant support for individuals who propose to use transgenic or gene knockout animals. This facility is located in the ICT and consists of two animal rooms that house stock animals, a surgical suite with two microinjection stations, and an additional room containing two CO2 incubators. As proposed, the facility would bill principal investigators only for the cost of consumables. Dr. Ho proposes to produce four transgenic F0 animals per project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Center Core Grants (P30)
Project #
5P30ES006639-09
Application #
6597605
Study Section
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
9
Fiscal Year
2002
Total Cost
$174,086
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Nakajima, Kosei; Kho, Dhong Hyo; Yanagawa, Takashi et al. (2016) Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis. Cancer Res 76:1391-402
Dombkowski, Alan A; Batista, Carlos E; Cukovic, Daniela et al. (2016) Cortical Tubers: Windows into Dysregulation of Epilepsy Risk and Synaptic Signaling Genes by MicroRNAs. Cereb Cortex 26:1059-71
Sanders, Matthew A; Madoux, Franck; Mladenovic, Ljiljana et al. (2015) Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle. Cell Metab 22:851-60
Zhang, Yi; Chopp, Michael; Liu, Xian Shuang et al. (2015) MicroRNAs in the axon locally mediate the effects of chondroitin sulfate proteoglycans and cGMP on axonal growth. Dev Neurobiol 75:1402-19
Kim, Haejin; Johnson, Christine C (2014) The association between acetaminophen and asthma: is there anything to learn from the upper airways? Curr Opin Allergy Clin Immunol 14:25-8
Wu, Hongli; Yu, Yibo; David, Larry et al. (2014) Glutaredoxin 2 (Grx2) gene deletion induces early onset of age-dependent cataracts in mice. J Biol Chem 289:36125-39
D'Angelo, Rosemarie Chirco; Liu, Xu-Wen; Najy, Abdo J et al. (2014) TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells. Mol Cancer Res 12:1324-33
Deranieh, Rania M; He, Quan; Caruso, Joseph A et al. (2013) Phosphorylation regulates myo-inositol-3-phosphate synthase: a novel regulatory mechanism of inositol biosynthesis. J Biol Chem 288:26822-33
Dzinic, Sijana H; Kaplun, Alexander; Li, Xiaohua et al. (2013) Identification of an intrinsic determinant critical for maspin subcellular localization and function. PLoS One 8:e74502
Wang, Guohui; Liu, Gang; Wang, Xiaogang et al. (2012) ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer 12:225

Showing the most recent 10 out of 433 publications